SCHEMBL24492823

SCHEMBL24492823

c1ccc(-n2c3ccncc3c3cc(-c4cc(-c5cccc(-c6cccc(-c7cncnc7)c6)c5)cc(-c5cccc(-c6cccc(-c7cncnc7)c6)c5)c4)ccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.39
▸ CYP2A6 P11509 1/20 0.37
▸ DRD2 P14416 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ TNF P01375 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ RAF1 P04049 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK10 P53779 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ FGFR1 P11362 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24492900 0.91 CYP19A1 (0.42) CYP2A6DRD2L3MBTL1ALDH1A1MEN1
SCHEMBL24493048 0.91 CYP19A1 (0.36) ATMCYP2A6DRD2TNFALDH1A1
SCHEMBL24492822 0.90 MKNK1 (0.42) ATMKDM4EL3MBTL1TNFMEN1
SCHEMBL24493047 0.89 CYP19A1 (0.40) CYP2A6DRD2L3MBTL1ALDH1A1MEN1
SCHEMBL24492873 0.89 MKNK1 (0.39) DRD2MEN1KMT2AMAPTMAPK10
SCHEMBL24493239 0.88 ATM (0.49) ATMCYP2A6DRD2KDM4EL3MBTL1
SCHEMBL25946455 0.88 ATM (0.42) ATMKDM4EL3MBTL1TNFALDH1A1
SCHEMBL15945614 0.88 KDM4E (0.44) ATMKDM4EL3MBTL1ALDH1A1CYP1A2
SCHEMBL15855397 0.87 CDK4 (0.41) ATMKDM4EL3MBTL1TNFALDH1A1
SCHEMBL24492899 0.86 ATM (0.46) ATMDRD2KDM4EL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 ATM 3566/4885CYP2A6 2586/4885DRD2 2280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback